• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA-29a 在转化生长因子-β诱导的肝癌上皮间质转化的表观遗传调控中的作用。

Involvement of miRNA-29a in epigenetic regulation of transforming growth factor-β-induced epithelial-mesenchymal transition in hepatocellular carcinoma.

机构信息

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

出版信息

Hepatol Res. 2014 Aug;44(8):907-19. doi: 10.1111/hepr.12188. Epub 2013 Jul 21.

DOI:10.1111/hepr.12188
PMID:23789939
Abstract

AIM

Epithelial-mesenchymal transition (EMT) is a crucial process during cancer invasion and metastasis, which is accompanied by the suppressed expression of E-cadherin initiated by stimuli such as transforming growth factor (TGF)-β. Recent studies have shown that the epigenetic regulation of E-cadherin could be an alternate mechanism of EMT induction in hepatocellular carcinoma (HCC). miRNA-29a (miR-29a) is involved in the epigenetic regulation of genes by targeting DNA methyltransferases (DNMT), which methylate CpG islands to suppress the transcription of genes. We studied the involvement of miR-29a in TGF-β-induced EMT in HCC cells.

METHODS

We treated human HCC cell lines with TGF-β to induce EMT. To investigate DNA methylation in EMT, cells were treated with a methylation inhibitor, 5-Aza-2'-deoxycytidine (5-Aza) and methylation status of CpG islands in the E-cadherin promoter was examined using methylation-specific PCR. Precursor miR-29a (pre-miR-29a) was electroporated to force the expression of miR-29a in HCC cells in order to study the role of miR-29a in EMT.

RESULTS

TGF-β transformed HCC cells into a spindle-shaped morphology accompanied by a decrease of E-cadherin with the induction of methylation of its promoter. Pretreatment of the cells with 5-Aza blocked this suppression of E-cadherin, indicating the involvement of DNA methylation. TGF-β increased DNMT3B and DNMT1 and decreased miR-29a expression. The forced expression of miR-29a abrogated the suppression of E-cadherin induced by TGF-β.

CONCLUSION

miR-29a could regulate TGF-β-induced EMT by affecting DNA methylation via the suppression of DNMT. These observations reveal the epigenetic regulation of genes by miRNA as a unique mechanism of EMT in HCC.

摘要

目的

上皮-间充质转化(EMT)是癌症侵袭和转移的关键过程,其伴随着 E-钙黏蛋白的表达受到转化生长因子(TGF)-β等刺激的抑制。最近的研究表明,E-钙黏蛋白的表观遗传调控可能是肝癌(HCC)中 EMT 诱导的另一种机制。miRNA-29a(miR-29a)通过靶向 DNA 甲基转移酶(DNMT)参与基因的表观遗传调控,DNMT 使 CpG 岛甲基化,从而抑制基因的转录。我们研究了 miR-29a 在 TGF-β诱导的 HCC 细胞 EMT 中的作用。

方法

我们用 TGF-β处理人 HCC 细胞系以诱导 EMT。为了研究 EMT 中的 DNA 甲基化,用甲基化抑制剂 5-氮杂-2'-脱氧胞苷(5-Aza)处理细胞,并通过甲基化特异性 PCR 检测 E-钙黏蛋白启动子中 CpG 岛的甲基化状态。用电穿孔将前体 miR-29a(pre-miR-29a)转染入 HCC 细胞中,强制表达 miR-29a,以研究 miR-29a 在 EMT 中的作用。

结果

TGF-β将 HCC 细胞转化为纺锤形形态,同时伴随着 E-钙黏蛋白的减少,其启动子发生甲基化。用 5-Aza 预处理细胞可阻止 E-钙黏蛋白的这种抑制,表明存在 DNA 甲基化。TGF-β增加了 DNMT3B 和 DNMT1,同时降低了 miR-29a 的表达。强制表达 miR-29a 可消除 TGF-β诱导的 E-钙黏蛋白抑制。

结论

miR-29a 可通过抑制 DNMT 影响 DNA 甲基化来调节 TGF-β诱导的 EMT。这些观察结果揭示了 miRNA 对基因的表观遗传调控是 HCC 中 EMT 的一种独特机制。

相似文献

1
Involvement of miRNA-29a in epigenetic regulation of transforming growth factor-β-induced epithelial-mesenchymal transition in hepatocellular carcinoma.miRNA-29a 在转化生长因子-β诱导的肝癌上皮间质转化的表观遗传调控中的作用。
Hepatol Res. 2014 Aug;44(8):907-19. doi: 10.1111/hepr.12188. Epub 2013 Jul 21.
2
TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.转化生长因子-β在卵巢癌细胞上皮-间质转化过程中诱导DNA甲基化的整体变化。
Epigenetics. 2014 Nov;9(11):1461-72. doi: 10.4161/15592294.2014.971608.
3
DNA methylation of miR-200 clusters promotes epithelial to mesenchymal transition in human conjunctival epithelial cells.miR-200 簇的 DNA 甲基化促进人结膜上皮细胞的上皮间质转化。
Exp Eye Res. 2020 Aug;197:108047. doi: 10.1016/j.exer.2020.108047. Epub 2020 May 5.
4
DNMTs Are Involved in TGF-β1-Induced Epithelial-Mesenchymal Transitions in Airway Epithelial Cells.DNMTs 参与 TGF-β1 诱导的气道上皮细胞上皮-间充质转化。
Int J Mol Sci. 2022 Mar 10;23(6):3003. doi: 10.3390/ijms23063003.
5
MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.微小RNA-199b-5p减弱转化生长因子-β1诱导的肝细胞癌上皮-间质转化
Br J Cancer. 2017 Jul 11;117(2):233-244. doi: 10.1038/bjc.2017.164. Epub 2017 Jun 6.
6
Loss-of-function of miR-142 by hypermethylation promotes TGF-β-mediated tumour growth and metastasis in hepatocellular carcinoma.通过甲基化导致的miR-142功能丧失促进了转化生长因子-β介导的肝癌肿瘤生长和转移。
Cell Prolif. 2017 Dec;50(6). doi: 10.1111/cpr.12384. Epub 2017 Sep 30.
7
Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma.层粘连蛋白-5与转化生长因子-β1诱导肝细胞癌上皮-间质转化。
Gastroenterology. 2005 Nov;129(5):1375-83. doi: 10.1053/j.gastro.2005.09.055.
8
Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells.CD44与转化生长因子-β1在肝癌细胞上皮-间质转化过程中通过AKT/糖原合成酶激酶-3β/β-连环蛋白信号通路产生的协同作用。
Biochem Biophys Res Commun. 2016 Sep 2;477(4):568-574. doi: 10.1016/j.bbrc.2016.06.077. Epub 2016 Jun 16.
9
Involvement of DNMT 3B promotes epithelial-mesenchymal transition and gene expression profile of invasive head and neck squamous cell carcinomas cell lines.DNMT 3B的参与促进了侵袭性头颈部鳞状细胞癌细胞系的上皮-间质转化和基因表达谱。
BMC Cancer. 2016 Jul 8;16:431. doi: 10.1186/s12885-016-2468-x.
10
miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells.微小RNA-338-3p抑制肝癌细胞的上皮-间质转化和转移。
Oncotarget. 2016 Jun 17;8(42):71418-71429. doi: 10.18632/oncotarget.10138. eCollection 2017 Sep 22.

引用本文的文献

1
MiR-29a-3p inhibits fibrosis of diabetic kidney disease in diabetic mice downregulation of DNA methyl transferase 3A and 3B.MiR-29a-3p通过下调DNA甲基转移酶3A和3B抑制糖尿病小鼠的糖尿病肾病纤维化。
World J Diabetes. 2025 Apr 15;16(4):93630. doi: 10.4239/wjd.v16.i4.93630.
2
New Insights into the Role of miR-29a in Hepatocellular Carcinoma: Implications in Mechanisms and Theragnostics.miR-29a在肝细胞癌中的作用新见解:对机制及治疗诊断的启示
J Pers Med. 2021 Mar 18;11(3):219. doi: 10.3390/jpm11030219.
3
MicroRNA-29a inhibits cell proliferation and arrests cell cycle by modulating p16 methylation in cervical cancer.
微小RNA-29a通过调节宫颈癌中p16的甲基化来抑制细胞增殖并使细胞周期停滞。
Oncol Lett. 2021 Apr;21(4):272. doi: 10.3892/ol.2021.12533. Epub 2021 Feb 9.
4
Hepatocyte nuclear factor 4α and cancer-related cell signaling pathways: a promising insight into cancer treatment.肝细胞核因子 4α 与癌症相关细胞信号通路:癌症治疗的新视角。
Exp Mol Med. 2021 Jan;53(1):8-18. doi: 10.1038/s12276-020-00551-1. Epub 2021 Jan 18.
5
EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell Lung Carcinomas.EZH2和KDM6B的表达与非小细胞肺癌上皮-间质转化过程中的特定表观遗传特征相关。
Cancers (Basel). 2020 Dec 5;12(12):3649. doi: 10.3390/cancers12123649.
6
The possible role of Sirtuins and microRNAs in hepatocellular carcinoma therapy.Sirtuins 和 microRNAs 在肝细胞癌治疗中的可能作用。
Cell Cycle. 2020 Dec;19(23):3209-3221. doi: 10.1080/15384101.2020.1843813. Epub 2020 Nov 9.
7
Traditional Chinese Medicine Xiaoai Jiedu Recipe Suppresses the Development of Hepatocellular Carcinoma via Regulating the microRNA-29a/Signal Transducer and Activator of Transcription 3 Axis.中药消癌解毒方通过调控微小RNA-29a/信号转导与转录激活因子3轴抑制肝细胞癌的发展。
Onco Targets Ther. 2020 Jul 29;13:7329-7342. doi: 10.2147/OTT.S248797. eCollection 2020.
8
Genetic And Epigenetic Regulation Of E-Cadherin Signaling In Human Hepatocellular Carcinoma.人类肝细胞癌中E-钙黏蛋白信号传导的遗传与表观遗传调控
Cancer Manag Res. 2019 Oct 16;11:8947-8963. doi: 10.2147/CMAR.S225606. eCollection 2019.
9
MicroRNA-29a suppresses the invasion and migration of osteosarcoma cells by regulating the SOCS1/NF-κB signalling pathway through negatively targeting DNMT3B.微小 RNA-29a 通过负向调控 DNMT3B 抑制 SOCS1/NF-κB 信号通路从而抑制骨肉瘤细胞的侵袭和迁移。
Int J Mol Med. 2019 Oct;44(4):1219-1232. doi: 10.3892/ijmm.2019.4287. Epub 2019 Jul 24.
10
miR‑29a suppresses the growth and metastasis of hepatocellular carcinoma through IFITM3.miR-29a 通过 IFITM3 抑制肝癌的生长和转移。
Oncol Rep. 2018 Dec;40(6):3261-3272. doi: 10.3892/or.2018.6745. Epub 2018 Sep 28.